Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolomics Pilot Study on Intensive Care Acquired Muscle Weakness in Polytrauma (MIRACLE-II Study)

NCT03819959 is registered in ClinicalTrials.gov with Technical University of Munich as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03819959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolomics Pilot Study on Intensive Care Acquired Muscle Weakness in Polytrauma (MIRACLE-II Study)
Lead sponsor
Technical University of Munich
Phase
Observational
Overall status
Completed
Start date
March 24, 2019
Completion date
April 22, 2020
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical care, critical illness, critical illness myopathy, critical illness polyneuropathy, intensive care (icu) myopathy, metabolomics, muscle weakness